Treatment with ACS and APS showed a trend to upregulate IL-10 gene expression more effectively than TA (p = 0.670 and p = 0.452 respectively), but did not downregulate IL-6 as effectively as TA (p = 0.402) (Figure 4). This evidence concerns the gene IL10 and autoimmune polyendocrinopathy.